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Abstract
Retinal vein occlusion (RVO) is, beside diabetic retinopathy, the most common retinal vascular disease. RVO is asso-
ciated with many risk factors, both systemic and ocular. Among the systemic risk factors is hypertension. A 36-year- 
-old man came to the hospital because of impaired vision. Central retinal vein occlusion (CRVO) was diagnosed. The 
main reason for developing RVO was the untreated hypertension, which was diagnosed in the form of hypertensive 
crisis. The patient presented numerous additional CRVO risk factors that contributed to the development of the 
described pathology like: obesity, dyslipidaemia, hyperhomocysteinaemia, renal cancer. The authors suggested active 
examination for CRVO risk factors regardless of the age of patients.
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Introduction
Retinal vein occlusion (RVO) is, beside diabetic 
retinopathy, the most common retinal vascular dis-
ease [1, 2]. It is the fifth cause of blindness [3].
Two types of RVO are distinguished: central reti-
nal vein occlusion (CRVO) and branch retinal vein 
occlusion (BRVO) [1, 2]. The central retinal vein 
occlusion is usually caused by thrombus in the vein 
near lamina cribrosa [1]. The alterations in the cen-
tral retinal vein are secondary to sclerotic changes in 
nearly situated central retinal artery [1]. However, 
may also be combined with morphologically altered 
endothelium that resembles arterial endothelium [4]. 
The CRVO can be divided into two subtypes: non-
ischaemic and ischaemic [1, 2]. Ischaemic form is 
often more severe [1] and less frequent [5]. 
The central retinal vein occlusion is manifested by 
a painless vision disorder. The retina’s images reveal: 
dilated and tortuous veins, haemorrhages, oedema 
and cotton wool spots [1].
There are many risk factors of RVO, among them: 
hypertension [1, 5, 6], dyslipidaemia [1, 6], ma-
lignancies [5], obesity [6], hyperhomocysteinaemia 
[1, 5], abnormal coagulation [1, 5], genetic predis-
position [7].
The two main complications of RVO are macular 
oedema and retinal ischaemia leading to neovascu-
larization [8].
Case report
A 36-year-old man (BMI = 32.8 kg/m2), intellectual-
ly efficient, non-smoker, with negative family history 
of cardiovascular and ophthalmic diseases, was ad-
mitted to the emergency room because of blindness 
of the right eye for 3 days and high blood pressure.
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He suffered from cerebral palsy from birth.
During the hospitalization additional tests 
showed, further abnormalities, including:
• dyslipidaemia — total cholesterol: 5.84 mmol/L, 
high-density lipoprotein: 1.25 mmol/L, low- 
-density lipoprotein: 4.62 mmol/L, triglycerides: 
23.3 umol/L (Tab. I);
• hyperhomocysteinaemia — 23.3 umol/L;
• mutation of the MTHFR C677T gene — hetero-
zygote (genetic marker of the abnormal coagula-
tion);
• high blood pressure: 
 — 230/130 mm Hg as assessed with oBP, at ad-
mission,
 — 24-h ambulatory mean systolic and diastolic 
blood pressure of 152 and 89 mm Hg, respec-
tively, mean activity time BP: 156/93 mm Hg, 
mean sleep time BP: 135/75 mm Hg;
• ultrasound of the abdomen: hyperechoic focal 
lesion (predominantly solid + little fluid) in the 
middle part of the right kidney;
• computing tomography (CAT scan) of the abdo-
men (with contrast): a heterodense cystic-solid 
change of 19 mm diameter in the right kidney; 
non-uniform contrast enhancement;
• histopathological examination of the renal tu-
mour showed polycystic form of clear cell renal 
carcinoma;
• fundoscopy: right eye — papilloedema, haem-
orrhages and blurring of the optic disc and its 
margins, macular oedema, intraretinal haemor-
rhages and retinal oedema, dilated and tortuous 
retinal veins; left eye — single cotton wool spot, 
no other relevant changes;
• fluorescence angiography (Fig. 1): 
 — right eye: extensive ecchymosis of the blood 
in the posterior pole and on the periphery, the 
disc is swollen with blurred boundaries; along 
the large vascular trunks, around the disc and 
in the macula, extensive foci of soft exudates; 
numerous areas of blockade of fluorescence 
by the blood; interrupted blood flow in many 
vessels; late stagnation of the dye in the ves-
sels. The assessment of capillary circulation is 
practically impossible, but the clinical picture 
speaks for high ischaemia. Central retinal vein 
occlusion,
 — left eye — a single cotton-wool spot over the 
papilla; straightened blood vessels; without 
leakage or dye stagnation.
Discussion
In the presented case we report on severe RVO sec-
ondary to hypertensive crisis in a patient with renal 
tumour. 
Increased blood pressure is inherently associated 
with vascular damage. Mechanical stress caused by 
shearing forces causes endothelial dysfunction as 
measured by the reduced bioavailability of the nitric 
oxide, a potent vasodilatory factor. Concurrently, 
angiotensin II excess contributes to constriction of 
the vessels, which further confers risk of hyperten-
sion development. The examination of the retinal 
vessels may also show characteristic changes resulting 
from long-standing or uncontrolled hypertension. 
Narrowing of the vessels impairs capillary blood flow, 
which may lead to RVO, at extremes [9].
Tissue hypoxia promotes vascular endothelial 
growth factor (VEGF) production and release, which 
in turn leads to hyperperfusion. The VEGF excess is 
also claimed to be responsible for the initiation and 
progression of the oedema and ischaemia in RVO 
[9, 10].
The reported patient also presented two other 
common RVO risk factors, i.e.: dyslipidaemia and 
obesity. Both conditions are associated with insulin 
resistance and may further contribute to vessel dam-
age. The discussed pathomechanisms contribute to 
the development of hypertension at an early age [11].
The other factor which possibly added the risk 
of the development of the RVO in our patient was 
Table I. Laboratory tests
Laboratory test Test result Norm
Total cholesterol 5.84 mmol/L 3.60–5.20 mmol/L
High-density lipoprotein 1.25 mmol/L > 1.00 mmol/L
Low-density lipoprotein 4.62 mmol/L < 3.60 mmol/L
Triglycerides 1.21 mmol/L 0.30–1.70 mmol/L
Homocysteine 23.3 umol/L 5.0–13.9 umol/L
Figure 1. Fluorescence angiography
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a genetic propensity to hyperhomocysteinaemia. This 
condition is frequently associated with an enhanced 
resistive index (derived from carotid ultrasound) as 
well as with damage to the vascular endothelium 
[12, 13].
Literature also provides reports on the cases of pa-
tients in whom RVO had developed in the course of 
cancers, thus the RVO may be referred to as a para-
neoplastic syndrome. However, in the presented case 
the diagnosed tumour was least likely to play a key 
role in the RVO development, as it was at an early 
stage, unlike in the previous reports [14, 15].
Conclusions
The aetiology of CRVO in the presented case was 
multifactorial; however, hypertension was the most 
probable triggering factor.
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